StonvexLoading…
StonvexStonvexStonvexCore line items from XGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $66.58M | $55.64M | $52.55M | $45.56M |
Operating Income | $-14.07M | $-13.64M | $-22.84M | $-46.05M |
Net Income | $-19.95M | $-15.12M | $-23.69M | $-47.39M |
EPS (Diluted) | $-0.93 | $-0.83 | $-1.34 | $-2.77 |
Total Assets | $58.02M | $44.69M | $56.94M | $86.22M |
Total Liabilities | $40.57M | $35.15M | $34.25M | $43.76M |
Cash & Equivalents | $32.22M | $22.04M | $36.49M | $62.39M |
Free Cash Flow OCF − CapEx | $-14.27M | $-13.79M | $-15.29M | $-36.46M |
Shares Outstanding | 22.91M | 17.64M | 17.05M | 16.55M |